Related Experiment Video
Updated: Apr 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways
Abstract:
Transforming growth factor b (TGFb) signaling controls many cellular responses including proliferation, epithelial to mesenchymal transition and apoptosis, through the activation of canonical (Smad) as well as non-canonical (e.g., Par6) pathways. Previous studies from our lab have demonstrated that aPKC inhibition regulates TGFb receptor trafficking and signaling. Here, we report that downstream TGFb-dependent transcriptional responses in aPKC-silenced NSCLC cells were reduced compared with those of control cells, despite a temporal extension of Smad2 phosphorylation. We assessed SARA–Smad2–Smad4 association and observed that knockdown of aPKC increased SARA (also known as ZFYVE9) levels and SARA–Smad2 complex formation, increased cytoplasmic retention of Smad2 and reduced Smad2–Smad4 complex formation, which correlated with reduced Smad2 nuclear translocation. Interestingly, we also detected an increase in p38 MAPK phosphorylation and apoptosis in aPKC-silenced cells, which were found to be TRAF6-dependent. Taken together, our results suggest that aPKC isoforms regulate Smad and non-Smad TGFb pathways and that aPKC inhibition sensitizes NSCLC cells to undergo TGFb dependent apoptosis.
Insights
aPKC inhibition reduces TGFb-dependent gene expression in NSCLC cells by disrupting Smad nuclear translocation. This leads to increased apoptosis via p38 MAPK and TRAF6 signaling, suggesting aPKC as a therapeutic target.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Cancer Research
Background:
- Transforming growth factor beta (TGFb) signaling is crucial for cellular functions, involving both canonical (Smad) and non-canonical pathways.
- Previous research indicated that atypical protein kinase C (aPKC) inhibition affects TGFb receptor trafficking and signaling.
Purpose of the Study:
- To investigate the role of aPKC in regulating TGFb signaling pathways in non-small cell lung cancer (NSCLC).
- To elucidate how aPKC silencing impacts TGFb-dependent transcriptional responses and apoptosis in NSCLC cells.
Main Methods:
- Silencing of aPKC in NSCLC cells.
- Assessment of TGFb-dependent transcriptional responses.
- Analysis of Smad2 phosphorylation, SARA–Smad2–Smad4 association, and Smad2 nuclear translocation.
- Evaluation of p38 MAPK phosphorylation and apoptosis, including TRAF6 dependency.
Main Results:
- aPKC silencing reduced TGFb-dependent gene expression despite prolonged Smad2 phosphorylation.
- Knockdown of aPKC increased SARA levels and SARA–Smad2 complex formation, impairing Smad2–Smad4 association and nuclear translocation.
- Increased p38 MAPK phosphorylation and apoptosis were observed in aPKC-silenced cells, dependent on TRAF6.
Conclusions:
- aPKC isoforms regulate both Smad and non-Smad TGFb signaling pathways.
- Inhibition of aPKC sensitizes NSCLC cells to TGFb-induced apoptosis, highlighting a potential therapeutic strategy.
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Extrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

